BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 2:41:00 PM | Browse: 1131 | Download: 1073
Publication Name World Journal of Gastroenterology
Manuscript ID 6100
Country South Korea
Received
2013-10-02 10:36
Peer-Review Started
2013-10-02 20:31
To Make the First Decision
2013-11-04 20:24
Return for Revision
2013-11-05 19:01
Revised
2013-11-27 01:25
Second Decision
2014-01-05 15:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-05 15:14
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-03-03 17:28
Typeset the Manuscript
2014-03-25 20:40
Publish the Manuscript Online
2014-04-14 10:49
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Chemopreventive drugs: Mechanisms via inhibition of cancer stem cells in colorectal cancer
Manuscript Source Invited Manuscript
All Author List Tae Il Kim
Funding Agency and Grant Number
Corresponding Author Tae Il Kim, MD, PhD, Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, 50 Yonseiro, Seodaemun-gu, Seoul 120-752, South Korea. taeilkim@yuhs.ac
Key Words Colorectal cancer; Chemoprevention; Cancer stem cell; Carcinogenesis; Microenvironment
Core Tip To develop optimal chemopreventive agents, we need to target cells and pathways that are essential and critical to carcinogenesis: early tumorigenic changes of stem cells and signals for dedifferentiation may be good targets for chemoprevention. Major chemopreventive drugs, such as non-steroidal anti-inflammatory drugs, statins, proliferator-activated receptor γ agonists and metformin, have cancer stem cell (CSC)-suppressing effects via regulation of stem cell-regulating pathways, stem cell niche in the tumor microenvironment, and altered tumor metabolism. These stem cell-related steps in tumorigenesis could be critical targets for chemoprevention and CSC-targeted adjunctive treatment of colorectal cancer.
Publish Date 2014-04-14 10:49
Citation Kim TI. Chemopreventive drugs: Mechanisms via inhibition of cancer stem cells in colorectal cancer. World J Gastroenterol 2014; 20(14): 3835-3846
URL http://www.wjgnet.com/1007-9327/full/v20/i14/3835.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i14.3835
Full Article (PDF) WJG-20-3835.pdf
Full Article (Word) WJG-20-3835.doc
Manuscript File 6100-Review.docx
Answering Reviewers 6100-Answering Reviewers.pdf
Copyright License Agreement 6100-Copyright assignment.pdf
Peer-review Report 6100-Peer review(s).pdf
Scientific Editor Work List 6100-Scientific editor work list.doc